Dr. Brose on Next-Generation Sequencing in Thyroid Cancer

(2:22)

Marcia Brose, MD, PhD, expounds on what should be done for patients who progress on larotrectinib

(1:42)

Dr. Brose on Recent Advances in Papillary Thyroid Cancer

(1:14)

Dr. Brose Discusses BRAF Mutations in Thyroid Cancer

(1:20)

Dr. Brose on Repurposing Drugs to Treat Thyroid Cancer

(1:46)

Dr. Brose Discusses The Tolerability of Sorafenib in Thyroid Cancer

(1:9)

Marcia Brose, MD, PhD, describes how testing for TRK abnormalities are accomplished

(4:33)

Dr. Brose Describes the DECISION Trial

(57)

Official ಹಿಂದೂ🔥 ದೇಶದಲ್ಲಿರೋ🇳🇵ಈ ಜಾಗ ನೀವು ನೋಡೇ ಇರಲ್ಲ❌ Dr Bro

(17:15)

If NERF Was Like Video Games

(14:54)

Stranded 100 Hours on a Homemade Raft

(44:8)

Drive Thru's With Siblings Be Like 😂

(3:32)

How To Get More Candy Than Your Sibling Trick or Treating **Halloween Challenge**

(3:20)

Episode #211: Actinobacteria and Endotoxins in CIRS with Dr. Ritchie Shoemaker, MD

(1:50:43)

Marcia S. Brose, MD, PhD: The Stigma Of Thyroid Cancer

(5:39)

Dr. Brose Discusses Lenvatinib for the Treatment of Patients With Thyroid Cancer

(1:23)

Dr. Marcia Brose - Medical Oncologist

(3:1econd)

Dr. Brose on Vandetanib for Differentiated Thyroid Cancer

(1:56)

Dr. Brose Describes the DECISION Trial

(45)

Dr. Brose on the FACT2 Study and the Treatment of Anaplastic Thyroid Cancer

(57)

Dr. Brose on Unique Elements of the Lenvatinib Trial

(1:5)

Dr. Brose Discusses Updated Overall Survival Analysis of the DECISION Trial

(1:2)

Dr. Brose Discusses Lenvatinib and Sorafenib in Differentiated Thyroid Cancer

(2:47)

COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory differentiated t...

(4:9)

Marcia Brose, MD, PhD, provides opinion on who should be tested TRK fusions

(2:39)